Butterfly Network

Butterfly Network, Inc. designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment. It develops and provides a whole-body portable ultrasound scanner called the iQ Device and related hosted, web-based application, application programming interfaces and platform services, which the firm offer to physicians or other licensed health care providers. Its products include iQ+ Ultrasound, Butterfly Enterprise and iQ Vet. The company was founded by Jonathan M. Rothberg on January 25, 2011 and is headquartered in Burlington, MA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Butterfly Network reports Q4 growth, seeks CEO for tech scaling

Butterfly Network's Q4 2022 performance showed revenue growth and improved cost management.
The company's strengths lie in democratizing healthcare, international expansion, and cost efficiency.
Challenges include external factors affecting deployments and the ongoing CEO search.
Opportunities for growth include revenue expectations, product developments, and efficiency enhancements.

Butterfly Network reports stable Q1 revenue, eyes AI and home markets

Butterfly Network's Q1 2023 performance showed mixed results with flat revenue but improved margins and reduced EBITDA loss.
The company's strengths in democratizing medical imaging, AI utilization, and strong cash position position it well for future growth.
Challenges include product revenue decline, slower customer growth, and the need to address international distribution weaknesses.
Opportunities in AI, software expansion, home market penetration, and exciting developments offer avenues for future success.

Butterfly Network reports Q2 revenue, focuses on innovation and growth

Butterfly Network's Q2 2023 performance showed mixed results with growth in U.S. sales but a decline in international sales.
The company is leveraging core strengths, launching innovative products, and focusing on revenue growth initiatives.
Challenges include declining international sales and potential impact on current sales due to the upcoming iQ3 launch.
Opportunities lie in new product launches, e-commerce strategy, market expansion, and technology advancements beyond iQ3.

Butterfly Network reports Q3 revenue decline but eyes future growth

Butterfly Network's Q3 2023 performance reflects a strategic shift towards higher-margin offerings and improved operational efficiency.
The company's strengths in revolutionizing ultrasound imaging, education offerings, and partnerships position it for future growth.
Challenges include revenue decline, competitive landscape, and the need for sustained investment in R&D and operational improvements.
Opportunities in upcoming product launches, market expansion, and revenue-sharing agreements present avenues for growth and innovation.

Butterfly Network reports improved Q4 financials and plans expansion

Butterfly Network's financials improved in Q4 2023 with revenue decline but better margins.
Strategic focus on product innovation, global expansion, and revenue growth drivers.
Challenges include revenue decline, EBITDA loss, and potential regulatory impacts.
Opportunities lie in planned growth strategies, resource additions, and lobbying efforts.

Butterfly Network excels in Q1 2024, eyes global expansion

Butterfly Network's Q1 2024 showcased strong revenue growth and operational improvements.
While facing challenges with compliance and financial losses, the company is optimistic about growth.
Strategic priorities and innovative technologies position Butterfly for future success and market expansion.

Butterfly Network reports robust Q2 growth, eyes AI opportunities

Butterfly Network's Q2 performance reflects strong revenue growth, improved cost efficiency, and a positive outlook for the year. The company's strengths in sustainable revenue growth, AI advancements, and strategic partnerships enhance its competitive position. Challenges in regulatory compliance and market expansion require careful navigation, while opportunities in AI, partnerships, and clinical applications offer avenues for growth.

Butterfly Network posts robust Q3 results, eyes tech innovation for growth

Butterfly Network's Q3 2024 performance reflects strong revenue growth, improved profitability, and strategic initiatives for future expansion and innovation.
While facing challenges in managing EBITDA losses and regulatory compliance, the company's financial strength and growth outlook present a positive trajectory.
Opportunities in technological innovation, market expansion, and healthcare initiatives position Butterfly Network for sustained growth and competitive advantage in the industry.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

GUILFORD, Conn. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. to Report First Quarter 2021 Financial Results on May 13, 2021

Butterfly Network, Inc. to Report First Quarter 2021 Financial Results on May 13, 2021

GUILFORD, Conn. & NEW YORK--(BUSINESS WIRE)---- $BFLY #ButterflyiQ--Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly"), an innovative digital health company driving universal access to superior medical imaging, today announced the appointment of Timothy Trodden as Senior Vice President and Chief Human Resources Officer, effective April 19. In this newly created executive position, Mr. Trodden will oversee the development and implementation of Butterfly's people strategy to fit the company's scaling business. This wil

Butterfly Network Appoints Timothy Trodden to Management Team

Shockwave Medical

Which of these amazing medical technology companies is better for your portfolio for the next decade?

Better Healthcare Stock for the Next 10 Years: Butterfly Network vs. Shockwave Medical

Butterfly Network's debut earnings call last week was impressive, but might have spooked some investors.

This Medical Equipment Company's Recent Earnings Gave Investors Butterflies

Longview Acquisition Corp.

Longview Acquisition Corp. II is the new SPAC from Glenview Capital Management, the sponsor behind the first Longview Acquisition Corp.'s well-received business combination with Butterfly Network. Despite this strong track record of recent success, shares of the new Longview Acquisition Corp. II are trading at only a very slight premium to redemption value.

Longview Acquisition Corp. II: Follow-Up To Butterfly Network SPAC Trading Within Pennies Of Redemption Value

The ultrasound-imaging sensor specialist reported 2020 results.

Why Butterfly Network Stock Dropped Today

Butterfly Network Inc - Class A (BFLY) CEO Todd Fruchterman on Q4 2020 Results - Earnings Call Transcript

GUILFORD, Conn. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly” or the “Company”), a digital health company working to bring medical imaging to all and to advance global health equity, today announced financial results for the full year 2020 and provided a business update. “In 2020, Butterfly grew revenues by 68% to $46.3 million as probe sales continued to increase, driven by the further adoption of our technology by healthcare providers,” said Dr. Todd Fruchterm

Butterfly Network, Inc. Reports 2020 Financial Results

Butterfly Network (BFLY) stock is soaring on Monday even with there being a lack of news concerning the medical device company. The post BFLY Stock: Why Medical Device Play Butterfly Network Is Fluttering Higher Today appeared first on InvestorPlace.

BFLY Stock: Why Medical Device Play Butterfly Network Is Fluttering Higher Today

GUILFORD, Conn. and NEW YORK, March 22, 2021 /PRNewswire/ -- Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly"), an innovative digital health company that is working to democratize medical imaging and contribute to the aspiration of global health equity, will report full year 2020 financial results on March 29, 2021, after market close.

Butterfly Network, Inc. to Report Full Year 2020 Financial Results on March 29, 2021

Sorrento Therapeutics Inc

The risk-to-reward proposition has recently gotten a lot better for investors considering BNGO stock. Is it a buy for single digits?

Even Below the $10 Mark There Are Way Better Buys Than BioNano Genomics

GUILFORD, Conn. and NEW YORK, March 11, 2021 /PRNewswire/ -- Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly"), an innovative digital health company driving universal access to superior medical imaging, today announced the appointment of Stacey Pugh as Chief Commercial Officer, effective March 15 th.

Butterfly Network, Inc. Further Strengthens Management and Board with Key Additions

Butterfly Network has a strong balance sheet following the merger with SPAC Longview Acquisition Corp. The product is highly disruptive and has the potential to capture a large portion of a massive addressable market.

News for Butterfly Network Stock (BFLY)